Structural and epidemiological features of primate lymphotropic retroviruses. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Structural and epidemiological features of primate lymphotropic retroviruses.

Princess Takamatsu Symp. 1984;15:109-18. Unique Identifier : AIDSLINE MED/86111551
Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N

Abstract: Primate lymphotropic retroviruses (PLRV) have been isolated from man and various species of Old World monkeys. The human isolates adult T-cell leukemia virus (ATLV) or human T-cell leukemia virus (HTLV-I) are endemic among Japanese in the south-west of the country as well as Africans in both Africa and America. In these populations ATL and its lymphoma variant are also endemic and all these patients harbor the virus and have serum antibodies to viral env gene polypeptides gp68, gp46, p21 as well as core polypeptides p24, p19, and p15. ATLV and respective viral antibodies are very rare outside the endemic areas. Retroviruses structurally and serologically related have been found in various species of Old World monkeys especially in macaques. The human lymphadenopathy associated virus (LAV) later also known as HTLV-III most probably is the etiological agent of the acquired immunodeficiency syndrome (AIDS) in man and related syndromes. LAV/HTLV-III is highly endemic in certain parts of the population of America and Europe and apparently also in Africa. Human antisera react with viral envelope related gp120, gp100, gp46, and core related p24, p21, and p15 polypeptides. In our assays LAV/HTLV-III does not crossreact serologically with ATLV/HTLV-I and its major structural polypeptides may be related distantly to primate lymphotropic retroviruses (PLRVs) isolated from macaques but not to ATLV/HTLV-I.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/ETIOLOGY/ IMMUNOLOGY Africa Animal Antibodies, Viral/*ANALYSIS Germany Glycoproteins/ANALYSIS Haplorhini/*MICROBIOLOGY Human HTLV-BLV Viruses/*ANALYSIS/IMMUNOLOGY Leukemia/EPIDEMIOLOGY/IMMUNOLOGY Retroviridae Infections/EPIDEMIOLOGY Retroviridae Proteins/*ANALYSIS T-Lymphocytes JOURNAL ARTICLE REVIEW

KWDacquiredimmunodeficiencysyndrome/epidemiology/etiology/immunologyafricaanimalantibodies,viral/KWDanalysisgermanyglycoproteins/analysishaplorhini/KWDmicrobiologyhumanhtlv-blvviruses/KWDanalysis/immunologyleukemia/epidemiology/immunologyretroviridaeinfections/epidemiologyretroviridaeproteins/KWDanalysist-lymphocytesjournalarticlereview
860530
M8650238

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .